The 20 Best Minimal Change Disease Doctors near Bronx, NY

Andrew S. Bomback, MD, MPH, is a nephrologist who specializes in glomerular diseases and resistant hypertension. Dr. Bomback received his undergraduate degree from Harvard University and his medical degree from Columbia University College of Physicians and Surgeons. He completed residency in Internal Medicine and fellowships in Nephrology and Clinical Epidemiology at the University of North Carolina at Chapel Hill, where he was the Doc J. Thurston III Fellow in Nephrology and Hypertension. In 2009, he returned to Columbia University as an associate at the Center for Glomerular Diseases and is currently Assistant Professor of Medicine at Columbia University Medical Center. Dr. Bomback is a member of the ColumbiaDoctors Hypertension Center, a multi-disciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for patients with hypertension,Dr. Bomback has published over 100 peer-reviewed articles and book chapters on the subjects of chronic kidney disease, glomerular diseases, and hypertension. He is the co-author of the textbook, Chronic Kidney Disease and Hypertension Essentials, and an editor of the National Kidney Foundation's Primer on Kidney Diseases. He is the recipient of the 2013 Daniel V. Kimberg Junior Faculty Award for oustanding teaching of medical students and housestaff.Dr. Bomback's research interests focus on evaluating novel therapies for glomerular diseases. He currently serves as principal or co-investigator on clinical trials of new treatments for IgA nephropathy, membranous nephropathy, lupus glomerulonephritis, hereditary nephritis, C3 glomerulopathy, and focal segmental glomerulosclerosis. Dr. Bomback is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Membranoproliferative Glomerulonephritis, Glomerulonephritis, Membranous Nephropathy, Minimal Change Disease, and Kidney Transplant.

Pietro Canetta is a Nephrologist in New York, New York. Dr. Canetta is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Focal Segmental Glomerulosclerosis, Glomerulonephritis, Minimal Change Disease, IgA Nephropathy, and Kidney Transplant. Dr. Canetta is currently accepting new patients.

Frederick J. Kaskel, MD, PhD, is involved in basic and clinical investigations into the mechanisms of the major kidney disorders in pediatrics. He is particularly interested in the physiology and pathophysiology of normal and abnormal development and function of the kidneys throughout the critical periods of growth and maturation extending into adolescence and young adulthood. He is actively involved in a clinical trial funded by the National Institutes of Health (NIH) to find the most efficacious therapy for focal segmental glomerulosclerosis, one of the major causes of progressive glomerular disease, while investigating the molecular etiologies for its expression. Another NIH-supported study involves chronic kidney disease in children and how it affects their growth and neurocognitive development, and the risk factors for cardiovascular disease and renal progression. Dr. Kaskel is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease, Metabolic Acidosis, and Kidney Transplant.

Christine Sethna is a Pediatric Nephrologist in Lake Success, New York. Dr. Sethna is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Nephrotic Syndrome, Minimal Change Disease, Focal Segmental Glomerulosclerosis, Hypertension, and Kidney Transplant.

Howard Trachtman is a Pediatric Nephrologist in New York, New York. Dr. Trachtman is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Focal Segmental Glomerulosclerosis, Minimal Change Disease, Glomerulonephritis, Nephrotic Syndrome, and Kidney Transplant.

"Dr. Ali Gharavi is a kidney specialist with expertise in human genetics. He is the Harold Ames Hatch (II) Professor of Medicine and currently serves as Chair of the Department of Medicine at Columbia University Vagelos College of Physicians and Surgeons, and Physician-in-Chief, NewYork-Presbyterian Hospital/Columbia. He previously served as the Chief of the Division of Nephrology at NewYork-Presbyterian/Columbia University Irving Medical Center.The principal investigator on multiple research projects funded by the National Institutes of Health (NIH), Dr. Gharavi has specific interests in the genetics of kidney diseases, including IgA nephropathy and congenital abnormalities of the kidney and urinary tract. His research has identified genes and risk loci for many kidney diseases and has demonstrated the utility of sequencing for the diagnosis and management of patients with kidney disorders.""Owing to the recent progress in genomic technologies, we now have the opportunity to make a precise genetic diagnosis for many patients and individualize care based on the specific molecular mechanism of disease. My objective is to therefore bring personalized genomic medicine from the laboratory into patient care,"" says Dr. Gharavi. As Department Chair, he aims to enhance access to genomic medicine for patients and reduce disparities for underserved populations.After receiving his medical degree from George Washington University, Dr. Gharavi completed his Internal medicine residency at Mount Sinai Medical Center and fellowships in hypertension and nephrology, also at Mount Sinai. He then completed a postdoctoral fellowship in human genetics at Yale University School of Medicine. He previously held academic appointments at Yale University School of Medicine and Mount Sinai School of Medicine and hospital appointments at Mount Sinai Hospital. Dr. Gharavi is the author of over 200 peer-reviewed publications and has led national and International committees related to genetic testing and research for kidney disorders. He was a recipient of the Judson Daland Prize for Outstanding Clinical Investigation from the American Philosophical Society, the National Kidney Foundation Clinical Scientist Award, and Homer Smith Award from the American Society of Nephrology. He was elected to the American Society of Clinical Investigation and the American Association of Physicians.". Dr. Gharavi is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Focal Segmental Glomerulosclerosis, Nephrotic Syndrome, and Kidney Transplant.

Dr. Radhakrishnan is Professor of Medicine at Columbia University Medical Center. He is the Director of Clinical Services of the Nephrology Division. His clinical and research interests are the in the therapy of chronic kidney disease (including glomerular diseases and lupus kidney disease), hypertension and intensive care nephrology.He is a co-director of the hypertension center of Columbia UniverstiyHe is a fellow of the American Society of Nephrology and National Kidney Foundation. His commitment to medical education and patient care is exemplified by his numerous teaching awards and his inclusion in the Who's Who among America's Teachers & Educators, America's Best Doctors and Castle Connolly's Top Doctor. Dr. Radhakrishnan is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Focal Segmental Glomerulosclerosis, Glomerulonephritis, IgA Nephropathy, Chronic Kidney Disease, and Kidney Transplant.

"Kenar D. Jhaveri, MD, is Professor of Medicine and Associate Chief in the Division of Kidney Diseases and Hypertension at Northwell Health and Zucker School of Medicine at Hofstra/Northwell. He completed his residency training at Yale University New Haven Hospital in Internal Medicine and then a fellowship in Nephrology at New York Presbyterian Hospital-Weill Cornell campus. His clinical interests are in glomerular diseases and onconephrology( cancer and its effect on the kidney). He is the founding member of the American Society of Onconephrology. He is a columnist for the ASN Kidney News for the section called ""Detective Nephron."" His interest in nephrology education is vested in using creative ways of teaching nephrology to medical students, residents, and fellows. He has published on onconephrology, Glomerular diseases, AKI and also in using social media and other innovative tools (games, concept maps, role playing, creative writing) to make nephrology a fun and exciting field. His most recent projects are in learning about renal toxicities of targeted oncological agents, immunotherapies, and COVID related AKI and glomerular diseases.". Dr. Jhaveri is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Glomerulonephritis, Interstitial Nephritis, Low Potassium Level, Low Sodium Level, and Kidney Transplant.

Molly Fisher, D.O., is an Assistant Professor of Medicine in the Division of Nephrology at Montefiore Medical Center/ Albert Einstein College of Medicine. She earned her medical degree at Des Moines University in Des Moines, Iowa in 2011. She then completed her internal medicine residency at Stamford Hospital/ Columbia University College of Physicians and Surgeons in 2014, followed by a nephrology fellowship at Montefiore Medical Center/ Albert Einstein College of Medicine in 2017. Dr. Fisher is board certified in internal medicine and nephrology. Her areas of clinical expertise include management of resistant hypertension, out-of-office blood pressure monitoring and virally mediated kidney disease. She is a certified hypertension specialist and is the Director of the Montefiore Ambulatory Blood Pressure Monitoring Program and the Nephrology Division Remote Blood Pressure Monitoring Program. She also leads an HIV-Kidney Disease Clinic at the AIDS Center for Positive Living, one of the largest HIV clinics in the United States. She is an active member of the American Society of Nephrology and serves on the ASN In-Training Exam Committee. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Minimal Change Disease, and Protein Deficiency.

Anna Zolotnitskaya, MD, is Medical Director, Pediatric Dialysis at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Zolotnitskaya’s clinical focus is on pediatric dialysis and pediatric renal transplantation. She leads a multidisciplinary dialysis team that provides patient-centered, evidence-based care for children and young adults with end-stage kidney disease. After obtaining her Doctor of Medicine at St. Petersburg Pediatric Academy in St. Petersburg, Russia, in 1983, Dr. Zolotnitskaya completed her pediatrics internship at the same institution in 1984. She remained there to complete her pediatrics residency in 1989, before completing an additional pediatrics residency at Soroka Medical Center in Beer-Sheva, Israel, in 1994. Following this, Dr. Zolotnitskaya completed a pediatric nephrology fellowship at Montefiore Einstein in 1998, followed by an additional pediatrics residency at Columbia University College of Physicians and Surgeons, St. Luke’s-Roosevelt Hospital in 2001. Dr. Zolotnitskaya has been principal investigator and co-investigator in clinical trials that investigate medications employed for the care of children with advanced chronic kidney disease. Her work has been published in numerous peer-reviewed journals and abstracts, and she has given several invited presentations. She is also a reviewer for the Journal of Pediatrics: Clinical Practice. Dr. Zolotnitskaya is board certified by the American Board of Pediatric Nephrology, the American Board of Pediatrics and the Israeli Board of Pediatrics. She is a member of the American Academy of Pediatrics, the American Society of Nephrology and the American Society of Pediatric Nephrology. Dr. Zolotnitskaya is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Chronic Kidney Disease, and Glomerulonephritis.

Dr. Lwin had a medical degree from the Institute of Medicine I in Yangon, Myanmar. She would go on to finish her residency at St. Barnabas Hospital in the Bronx before completing a Nephrology fellowship at New York Medical College. She achieved Board recertificaton in Internal Medicine and Nephrology in 2009. Dr. Lwin is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), High Potassium Level, and Hypophosphatemia.

Dr. Yoo graduated from Seoul National University-Medical School in Korea 1967 and served in the Korean Air-Force as a Medical Officer 1967-1970. He completed his Medical Residency at NY Med College-Metropolitan Hospital in 1974 and his Nephrology Fellowship at NY Med College-Flower Fifth Hospital in 1976. Dr. Yoo is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Nephrotic Syndrome, and Glomerulonephritis.

Krzysztof Kiryluk is a Nephrologist in New York, New York. Dr. Kiryluk is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Focal Segmental Glomerulosclerosis, Membranous Nephropathy, and Kidney Transplant. Dr. Kiryluk is currently accepting new patients.

Dr. Hilda Fernandez is a Transplant Nephrologist who is board certified in Pediatric and Adult Nephrology. She is the Medical Director of the Pediatric Kidney Transplant Program at NewYork-Presbyterian Morgan Stanley Children’s Hospital. Dr. Fernandez is a native Californian who trained at UCLA for Internal Medicine-Pediatric Combined Residency, followed by Pediatric Nephrology Fellowship. She then completed an adult Nephrology Fellowship at the University of Pennsylvania, followed by completion of her Masters of Science in Clinical Epidemiology. Dr. Fernandez subsequently moved to New York City to complete her Transplant Fellowship at NewYork-Presbyterian Morgan Stanley Children’s Hospital-Columbia University Irving Medical Center, and she has been a member of the faculty since 2015. Dr. Fernandez has research interests in kidney transplant outcomes. She is also an expert on the transition of care from pediatric to adult care practices. Dr. Fernandez is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are End-Stage Renal Disease (ESRD), Minimal Change Disease, Focal Segmental Glomerulosclerosis, Chronic Kidney Disease, and Kidney Transplant.

Simone Cherchi is a Nephrologist in New York, New York. Dr. Cherchi is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Focal Segmental Glomerulosclerosis, Nephrotic Syndrome, Glomerulonephritis, Chronic Kidney Disease, and Kidney Transplant.

Dr. Rao is an Associate Professor of Medicine in the Division of Nephrology at Columbia University, where she has been on the faculty since 2009. She is the Director of the Chronic Kidney Disease Program at Columbia. She is also currently the chief of Medicine at the Allen Hospital, part of the NYP system. Previously, she has been the medical director of several outpatient dialysis units. Her clinical interests are in pre-dialysis kidney disease. She also has an interest in caring for older adults with kidney disease, focusing on dialysis decision making and initiating a palliative approach for patients who choose to forgo dialysis for active medical management of their kidney disease. In addition, she is a member of the ColumbiaDoctors Hypertension Center, a multi-disciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for patients with hypertension. Dr. Rao has previously done work in health care disparities and chronic kidney disease. Her current research interests are in geriatric nephrology. She had a NIH grant to study the ideal vascular access in older adults preparing for dialysis. She currently is the site leader for a NIH funded study evaluating a tool to guide the decision making around dialysis in older and frail adults. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Chronic Kidney Disease, Nephrosclerosis, Renovascular Hypertension, Goodpasture Syndrome, and Kidney Transplant.

Jordan Rosenstock is a Nephrologist in New York, New York. Dr. Rosenstock is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Chronic Kidney Disease, Glomerulonephritis, Acute Kidney Failure, and Nephrotic Syndrome.

Krishan Gupta is a primary care provider, practicing in Internal Medicine in Bronx, New York. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Glomerulonephritis, Membranous Nephropathy, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Russell Crew is a Nephrologist in New York, New York. Dr. Crew is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Tubular Necrosis, Acute Kidney Failure, and Kidney Transplant. Dr. Crew is currently accepting new patients.

Samriti Dogra is a Pediatrics specialist and a Pediatric Nephrologist in New York, New York. Dr. Dogra is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Glomerulonephritis, Nephrotic Syndrome, Minimal Change Disease, and Posterior Urethral Valves. Dr. Dogra is currently accepting new patients.